Strategic Pricing and Market Access for 505(b)(2) Therapeutics: A Framework for Optimal Launch
In the rapidly evolving landscape of pharmaceutical innovation, the successful launch of 505(b)(2) therapeutics hinges on more than just groundbreaking science—it demands a strategic approach to pricing and market access that maximizes value while navi…
